Prostate-specific Antigen Nadir and Time to Nadir Predict Recurrence in Postprostatectomy Patients Treated with Salvage Radiotherapy Without Androgen Deprivation Therapy

Our study showed that the combination of PSA nadir depth and TTN after SRT allows an improvement in prognostic stratification of SRT patients with BCR after RP. These findings might improve patient-tailored decisions between surveillance, active treatment, and treatment escalation.

Authors

Institutions

Publication Details

Journal
European Urology Oncology
Published
2025-12-01
DOI
https://doi.org/10.1016/j.euo.2025.12.001
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prostate-specific Antigen Nadir and Time to Nadir Predict Recurrence in Postprostatectomy Patients Treated with Salvage Radiotherapy Without Androgen Deprivation Therapy

Riccardo Villa, Alessandro Magli, Filippo Alongi, Alessandra Donofrio et al.
European Urology Oncology
Prostate Cancer Diagnosis and Treatment
article

Prostate-specific Antigen Nadir and Time to Nadir Predict Recurrence in Postprostatectomy Patients Treated with Salvage Radiotherapy Without Androgen Deprivation Therapy

Riccardo Villa, Alessandro Magli, Filippo Alongi, Alessandra Donofrio, Giorgia Timon, Mattia Zaffaroni, Nicola Simoni, Giulio Francolini, Federico Mastroleo, Luca Triggiani, Corrado Spatola, Marcin Miszczyk, Vincenzo Burgio, Ciro Franzese, Maja Hasterok, Luca Nicosia, Barbara Alicja Jereczek-Fossa, Salvina Barra, Giulia Marvaso, Maria Giulia Vincini, Fabio Matrone, Marta Scorsetti, Stefano Arcangeli, Matteo Augugliaro
article en

Abstract

Our study showed that the combination of PSA nadir depth and TTN after SRT allows an improvement in prognostic stratification of SRT patients with BCR after RP. These findings might improve patient-tailored decisions between surveillance, active treatment, and treatment escalation.

European Urology Oncology
University of Parma (IT), Humanitas University (IT), University of Catania (IT), Azienda Sanitaria Unità Locale di Reggio Emilia (IT), Comprehensive Cancer Center Vienna (AT), Ospedale Sacro Cuore Don Calabria (IT), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Azienda Ospedaliero-Universitaria Careggi (IT), National Institute of Oncology (HU), Centro di Riferimento Oncologico (IT), Ospedale Policlinico San Martino (IT), The Maria Sklodowska-Curie National Research Institute of Oncology (PL), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo (IT), IRCCS Humanitas Research Hospital (IT), Azienda Sanitaria Universitaria Integrata di Trieste (IT), European Institute of Oncology (IT), University of Milano-Bicocca (IT)
Openalex Percentile: Top 40%
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.